Lifecore Biomedical, Inc. LFCR Income from Discontinued Ops
Discontinued — last reported Q4 '25
Income from Discontinued Ops at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Lifecore Biomedical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare.
The official record: Lifecore Biomedical, Inc.’s 10-K, filed August 7, 2025, on SEC EDGAR. View the filing →
Ask your AI about Lifecore Biomedical, Inc.'s income from discontinued ops.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lifecore Biomedical, Inc.'s income from discontinued ops?
- Lifecore Biomedical, Inc. (LFCR) reported income from discontinued ops of $0.00 in Q1 2025.
- How has Lifecore Biomedical, Inc.'s income from discontinued ops changed year-over-year?
- Lifecore Biomedical, Inc.'s income from discontinued ops decreased by 100.0% year-over-year, from $3,000.00 to $0.00.
- What is the long-term trend for Lifecore Biomedical, Inc.'s income from discontinued ops?
- Over 3 years (2022 to 2025), Lifecore Biomedical, Inc.'s income from discontinued ops has grown at a -100.0% compound annual growth rate (CAGR), from -$101,239,000.00 to $0.00.
- What does income from discontinued ops mean?
- Gains or losses from business segments that have been sold, abandoned, or classified as held for sale, reported net of applicable income taxes.